N@N

Is The Alzheimer's Drug Leqembi Covered By Medicare?

Leqembi, a new Alzheimer’s treatment, has been approved by the FDA with full traditional approval, making it eligible for Medicare coverage. Previously, Medicare coverage for Alzheimer’s treatments was limited to those in clinical trials. Now, with Leqembi's approval, Medicare will cover the drug for patients with mild cognitive impairment or mild dementia due to Alzheimer’s, provided they are enrolled in Medicare Part B and their healthcare provider participates in a registry that collects data on the drug's effectiveness in real-world settings. This coverage decision marks a significant shift in policy, aiming to provide broader access to innovative treatments while still gathering necessary data on their performance outside of clinical trials. However, patients might still face out-of-pocket costs, and the coverage is contingent on the drug's registry participation.

Read the Full Forbes Article at:
[ https://www.forbes.com/advisor/health-insurance/medicare/leqembi-medicare/ ]